D-66201-001 Class II Terminated
FDA drug recall D-66201-001 was initiated by Hospira Inc. on Aug 29, 2013 and is designated Class II. Reason for recall: Presence of Particulate Matter; report of visible particulates in the glass ampule The recall status is terminated (terminated Nov 10, 2014). Affected quantity: 86,400 ampuls.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 9, 2013
- Initiation Date
- Aug 29, 2013
- Termination Date
- Nov 10, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 86,400 ampuls
Product Description
5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
Reason for Recall
Presence of Particulate Matter; report of visible particulates in the glass ampule
Distribution Pattern
Nationwide
Code Information
Lot 23-227-DK
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-66201-001
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026